Spruce Biosciences, Inc.
USD56.85
+0.97 (+1.74%)
CEO
Javier Szwarcberg
IPO Date
2020-10-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$55.17
Prev. Close
$55.88
Day Low
$55.17
Day High
$57.00
52W Low
$7.00
52W High
$838.13
Market Cap
$0.08B
Volume
0.01M
| -0.3 |
| 31 Dec 2023 | FY | 100.0% | -475.0% | -62.6% | -46.1% | 0.06 | 4.18 | -2.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -67.4% | -53.9% | 0.09 | 6.72 | -1.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -38.0% | -33.4% | 0.06 | 10.36 | -4.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -19.8% | -18.1% | 0.04 | 16.43 | -37.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 43.2% | -282.1% | -0.15 | 1.08 | -55.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 55.4% | -206.5% | 0.00 | 1.76 | -2.6 |
| -1.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -152.5% | -53.6% | 0.25 | 1.54 | -0.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -15.7% | -9.5% | 0.14 | 2.60 | -0.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -91.6% | -44.4% | 0.15 | 1.95 | -0.2 |
| 31 Dec 2024 | Q4 | 100.0% | -3380.1% | -81.7% | -52.1% | 0.10 | 2.90 | -0.2 |
| 30 Sept 2024 | Q3 | 100.0% | -1440.4% | -16.8% | -13.3% | 0.06 | 5.36 | -0.6 |
| 30 Jun 2024 | Q2 | 100.0% | -570.2% | -15.5% | -12.2% | 0.06 | 5.17 | -0.6 |
| 31 Mar 2024 | Q1 | 100.0% | -580.7% | -17.4% | -13.3% | 0.06 | 4.67 | -0.7 |
| 31 Dec 2023 | Q4 | 99.4% | -344.6% | -13.0% | -9.6% | 0.06 | 4.18 | -2.9 |